Genetic screening and testing can help detect powerful information to inform healthcare decisions and improve patient outcomes. Whether you’re planning the healthiest pregnancy possible or want to understand your risk of developing certain cancers, genes can be your guide.

Illuminating the path to better health through genetic insights Our tests and screens reveal information to guide patients and providers to better health and well-being. Whether you’re searching for answers related to cancer risk, cancer treatment, prenatal care or mental health, Myriad screens and tests can help.

Learn about Myriad Genetics, the importance of our mission and vision and how it drives everything we do in our pursuit to advance health and well-being for all.

Illuminating the path to better health through genetic insights

Join Myriad Genetics, a leader in genetic testing and precision medicine, and be part of a diverse team dedicated to advancing health and well being for all.

Myriad Genetics laboratory and support center Still have questions? Contact our dedicated service team for answers. For GeneSight sales questions and support, contact us here. 322 North 2200 West Salt Lake City, UT 84116 Corporate Phone: (801) 584-3600 Corporate Fax: (801) 584-3640 Customer Service Hours: Mon-Fri: 8am-8pm EST

Find out how MyRisk comprehensive risk assessments provide actionable genetic testing insights to help patients and providers make informed medical decisions.

Myriad makes genetic testing simple with clear, actionable results. We created easy-to-understand reports to ensure that both you and your clinician can use the information to guide …

Myriad Genetics is a leading molecular diagnostic company dedicated to saving lives and improving the quality of life for patients through the discovery and commercialization of novel, transformative diagnostic tests for several major diseases, including cancer, rheumatoid arthritis, diabetes and more.

MyRisk is a genetic test that evaluates 48 genes to determine your risk of developing 11 different types of hereditary cancer. When coupled with RiskScore ®, it can assess a patient’s five-year and lifetime risk of developing breast cancer.